Quantcast
Last updated on April 16, 2014 at 14:14 EDT

Latest hepatitis C Stories

2013-06-20 12:31:54

First U.S. Food and Drug Administration (FDA)-approved hepatitis C genotyping test is now available in the U.S. to help physicians improve patient care. ABBOTT PARK, Ill., June 20, 2013 /PRNewswire/ -- Abbott announced today that it has introduced the first FDA-approved hepatitis C virus (HCV) genotyping test for patients in the United States. Abbott's fully automated RealTime HCV Genotype II test determines the specific type or strain (referred to as the genotype) of the HCV virus...

2013-06-17 20:20:44

International Coalition of Hepatitis C Survivors band together to raise awareness, fund research, and find a cure NEW YORK, June 17, 2013 /PRNewswire/ -- Today in New York the World Hepatitis Fund launched a bold new initiative to harness the power of social media to educate, diagnose and treat the nearly two hundred million people worldwide who have contracted Hepatitis C. Hepatitis C, also known as the silent killer is the leading cause of liver cancer and the need for liver...

2013-06-13 16:25:56

RnR Market Research adds new HCV Drugs market research reports by GlobalData for US, Japan, Brazil China, France, Germany, Italy, Spain and the UK with an in-depth analysis on the companies in these countries. DALLAS, June 13, 2013 /PRNewswire-iReach/ -- RnRMarketResearch.com now offers new market research reports on the Hepatitis C Virus drug industry for US, Japan, Brazil China, France, Germany, Italy, Spain and the UK with an in-depth analysis on the companies in these countries....

2013-06-12 23:17:24

Hep B United joins the Centers for Disease Control and Prevention (CDC) in announcing the first-ever multilingual campaign for Asian Americans and Pacific Islanders (AAPIs), to increase testing for hepatitis B among this population across the United States. WASHINGTON, D.C. (PRWEB) June 12, 2013 Hep B United joins the Centers for Disease Control and Prevention (CDC) in announcing the first-ever multilingual campaign for Asian Americans and Pacific Islanders (AAPIs), to increase testing for...

2013-06-11 12:24:49

One Third of Surveyed Specialists in the EU5 were Unable to Cite Any New Therapy in Development for HCV, According to a New Report from BioTrends Research Group EXTON, Pa., June 11, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds in their TreatmentTrends(®): Hepatitis C Virus (EU) report, that surveyed gastroenterologists and hepatologists in Spain and France are more likely to...

2013-06-11 11:13:32

Loyola researchers identify disruption of iron uptake receptor Hepatitis C virus (HCV) infects more than 170 million people worldwide. Approximately 80 percent of infections lead to chronic illness including fibrosis, cirrhosis, cancer and also hepatic iron overload. A new study completed by researchers at Loyola University Chicago Stritch School of Medicine reveals that HCV not only alters expression of the iron-uptake receptor known as transferrin receptor 1 (TfR1) but that TfR1 also...

2013-06-10 12:26:48

NEW YORK, June 10, 2013 /PRNewswire-USNewswire/ -- The National Black Leadership Commission on AIDS, Inc. (NBLCA) is working in partnership with allied organizations to advocate for the passage of New York State Senate (S2750) and Assembly (A1286) bills to expand access to testing for the Hepatitis C virus (HCV), which has reached epidemic proportions in New York and the United States. The proposed legislation would require hospitals and health care practitioners to offer Hepatitis C...

2013-06-04 12:26:04

Expansion of Therapies Offering Benefits Over Current Standard of Care Will Drive Growth Despite Price Controls in Market, According to a New Report from Decision Resources BURLINGTON, Mass., June 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that, from 2012 to 2017, the hepatitis C virus (HCV) market in Turkey will more than triple, reaching $275 million in 2017. The Emerging...

2013-06-03 23:22:25

Avail is conducting a 12-week, Phase 2, Randomized Study to Evaluate the Safety and Efficacy of a new drug in Subjects with Chronic Hepatitis C Infection. DeLand, Florida (PRWEB) June 03, 2013 *To see if you qualify for this Hepatitis C Clinical Trial, visit Avail Clinical Research on the web or contact us directly at (386) 785-2404. BACKGROUND The Hepatitis C virus (HCV) infection is a global public health problem. The global prevalence of hepatitis C infection is estimated to average 3%...

2013-05-23 12:26:49

Sixty Percent of Surveyed Physicians Agree That They Are Beginning To Warehouse HCV Patients Until New Interferon-Free Regimens Are Available, According to a Recently Published BioTrends Report EXTON, Pa., May 23, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, unaided, one in five surveyed gastroenterologists, hepatologists, and infectious disease specialists reported that in...


Latest hepatitis C Reference Libraries

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

More Articles (1 articles) »